Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program
Since March 2014, the quadrivalent HPV vaccine has been incorporated into the Brazilian Unified Health Care System and began to be offered, without direct costs, for girls from 9 to 13 years of age. Older female adolescents would have the option to be vaccinated at private health care system being r...
Saved in:
| Published in: | BMC public health Vol. 20; no. 1; p. 458 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
BioMed Central Ltd
06-04-2020
BioMed Central BMC |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Since March 2014, the quadrivalent HPV vaccine has been incorporated into the Brazilian Unified Health Care System and began to be offered, without direct costs, for girls from 9 to 13 years of age. Older female adolescents would have the option to be vaccinated at private health care system being responsible for the payment of HPV vaccine. The present study aimed to evaluate the coverage rates and predictors of HPV vaccination in Brazil among two groups of female adolescents: eligible and non-eligible for the HPV vaccination public program.
We used data from the 2015 Brazilian National Adolescent School-Based Health Survey, which involved a probabilistic sample of 5404 female adolescents students at public and private schools. Using a questionnaire, we gathered information on sociodemographic characteristics, sexual behavior, and respondent perception of parental supervision and have been vaccinated for HPV. Age-specific vaccination rates were analyzed in girls aged 9 to 13 at the time of public vaccination (eligible for public policy), as well among those 14 to 17 years old not eligible by the Ministry of Health for vaccination. We used Poisson regression models to investigate associated factors.
HPV vaccine coverage was 83.5 and 21.8% among eligible and non-eligible populations, respectively. In both populations, the chance of being vaccinated decreased with older age. In the eligible population there is a greater chance of being vaccinated among ethnic group "pardas" but not with other indicators of socioeconomic status. In the non-eligible population, there was a clear association between higher vaccine coverage and greater maternal education and living with the mother.
Our findings highlight the importance of public policies to minimize inequities in access to cancer prevention measures in vulnerable adolescents. A public policy of HPV vaccination for older female adolescents would increase coverage with possible reduction of HPV-related diseases in this group of women. |
|---|---|
| AbstractList | Background Since March 2014, the quadrivalent HPV vaccine has been incorporated into the Brazilian Unified Health Care System and began to be offered, without direct costs, for girls from 9 to 13 years of age. Older female adolescents would have the option to be vaccinated at private health care system being responsible for the payment of HPV vaccine. The present study aimed to evaluate the coverage rates and predictors of HPV vaccination in Brazil among two groups of female adolescents: eligible and non-eligible for the HPV vaccination public program. Methods We used data from the 2015 Brazilian National Adolescent School-Based Health Survey, which involved a probabilistic sample of 5404 female adolescents students at public and private schools. Using a questionnaire, we gathered information on sociodemographic characteristics, sexual behavior, and respondent perception of parental supervision and have been vaccinated for HPV. Age-specific vaccination rates were analyzed in girls aged 9 to 13 at the time of public vaccination (eligible for public policy), as well among those 14 to 17 years old not eligible by the Ministry of Health for vaccination. We used Poisson regression models to investigate associated factors. Results HPV vaccine coverage was 83.5 and 21.8% among eligible and non-eligible populations, respectively. In both populations, the chance of being vaccinated decreased with older age. In the eligible population there is a greater chance of being vaccinated among ethnic group “pardas” but not with other indicators of socioeconomic status. In the non-eligible population, there was a clear association between higher vaccine coverage and greater maternal education and living with the mother. Conclusion Our findings highlight the importance of public policies to minimize inequities in access to cancer prevention measures in vulnerable adolescents. A public policy of HPV vaccination for older female adolescents would increase coverage with possible reduction of HPV-related diseases in this group of women. Since March 2014, the quadrivalent HPV vaccine has been incorporated into the Brazilian Unified Health Care System and began to be offered, without direct costs, for girls from 9 to 13 years of age. Older female adolescents would have the option to be vaccinated at private health care system being responsible for the payment of HPV vaccine. The present study aimed to evaluate the coverage rates and predictors of HPV vaccination in Brazil among two groups of female adolescents: eligible and non-eligible for the HPV vaccination public program. We used data from the 2015 Brazilian National Adolescent School-Based Health Survey, which involved a probabilistic sample of 5404 female adolescents students at public and private schools. Using a questionnaire, we gathered information on sociodemographic characteristics, sexual behavior, and respondent perception of parental supervision and have been vaccinated for HPV. Age-specific vaccination rates were analyzed in girls aged 9 to 13 at the time of public vaccination (eligible for public policy), as well among those 14 to 17 years old not eligible by the Ministry of Health for vaccination. We used Poisson regression models to investigate associated factors. HPV vaccine coverage was 83.5 and 21.8% among eligible and non-eligible populations, respectively. In both populations, the chance of being vaccinated decreased with older age. In the eligible population there is a greater chance of being vaccinated among ethnic group "pardas" but not with other indicators of socioeconomic status. In the non-eligible population, there was a clear association between higher vaccine coverage and greater maternal education and living with the mother. Our findings highlight the importance of public policies to minimize inequities in access to cancer prevention measures in vulnerable adolescents. A public policy of HPV vaccination for older female adolescents would increase coverage with possible reduction of HPV-related diseases in this group of women. Abstract Background Since March 2014, the quadrivalent HPV vaccine has been incorporated into the Brazilian Unified Health Care System and began to be offered, without direct costs, for girls from 9 to 13 years of age. Older female adolescents would have the option to be vaccinated at private health care system being responsible for the payment of HPV vaccine. The present study aimed to evaluate the coverage rates and predictors of HPV vaccination in Brazil among two groups of female adolescents: eligible and non-eligible for the HPV vaccination public program. Methods We used data from the 2015 Brazilian National Adolescent School-Based Health Survey, which involved a probabilistic sample of 5404 female adolescents students at public and private schools. Using a questionnaire, we gathered information on sociodemographic characteristics, sexual behavior, and respondent perception of parental supervision and have been vaccinated for HPV. Age-specific vaccination rates were analyzed in girls aged 9 to 13 at the time of public vaccination (eligible for public policy), as well among those 14 to 17 years old not eligible by the Ministry of Health for vaccination. We used Poisson regression models to investigate associated factors. Results HPV vaccine coverage was 83.5 and 21.8% among eligible and non-eligible populations, respectively. In both populations, the chance of being vaccinated decreased with older age. In the eligible population there is a greater chance of being vaccinated among ethnic group “pardas” but not with other indicators of socioeconomic status. In the non-eligible population, there was a clear association between higher vaccine coverage and greater maternal education and living with the mother. Conclusion Our findings highlight the importance of public policies to minimize inequities in access to cancer prevention measures in vulnerable adolescents. A public policy of HPV vaccination for older female adolescents would increase coverage with possible reduction of HPV-related diseases in this group of women. Since March 2014, the quadrivalent HPV vaccine has been incorporated into the Brazilian Unified Health Care System and began to be offered, without direct costs, for girls from 9 to 13 years of age. Older female adolescents would have the option to be vaccinated at private health care system being responsible for the payment of HPV vaccine. The present study aimed to evaluate the coverage rates and predictors of HPV vaccination in Brazil among two groups of female adolescents: eligible and non-eligible for the HPV vaccination public program. We used data from the 2015 Brazilian National Adolescent School-Based Health Survey, which involved a probabilistic sample of 5404 female adolescents students at public and private schools. Using a questionnaire, we gathered information on sociodemographic characteristics, sexual behavior, and respondent perception of parental supervision and have been vaccinated for HPV. Age-specific vaccination rates were analyzed in girls aged 9 to 13 at the time of public vaccination (eligible for public policy), as well among those 14 to 17 years old not eligible by the Ministry of Health for vaccination. We used Poisson regression models to investigate associated factors. HPV vaccine coverage was 83.5 and 21.8% among eligible and non-eligible populations, respectively. In both populations, the chance of being vaccinated decreased with older age. In the eligible population there is a greater chance of being vaccinated among ethnic group "pardas" but not with other indicators of socioeconomic status. In the non-eligible population, there was a clear association between higher vaccine coverage and greater maternal education and living with the mother. Our findings highlight the importance of public policies to minimize inequities in access to cancer prevention measures in vulnerable adolescents. A public policy of HPV vaccination for older female adolescents would increase coverage with possible reduction of HPV-related diseases in this group of women. BACKGROUNDSince March 2014, the quadrivalent HPV vaccine has been incorporated into the Brazilian Unified Health Care System and began to be offered, without direct costs, for girls from 9 to 13 years of age. Older female adolescents would have the option to be vaccinated at private health care system being responsible for the payment of HPV vaccine. The present study aimed to evaluate the coverage rates and predictors of HPV vaccination in Brazil among two groups of female adolescents: eligible and non-eligible for the HPV vaccination public program. METHODSWe used data from the 2015 Brazilian National Adolescent School-Based Health Survey, which involved a probabilistic sample of 5404 female adolescents students at public and private schools. Using a questionnaire, we gathered information on sociodemographic characteristics, sexual behavior, and respondent perception of parental supervision and have been vaccinated for HPV. Age-specific vaccination rates were analyzed in girls aged 9 to 13 at the time of public vaccination (eligible for public policy), as well among those 14 to 17 years old not eligible by the Ministry of Health for vaccination. We used Poisson regression models to investigate associated factors. RESULTSHPV vaccine coverage was 83.5 and 21.8% among eligible and non-eligible populations, respectively. In both populations, the chance of being vaccinated decreased with older age. In the eligible population there is a greater chance of being vaccinated among ethnic group "pardas" but not with other indicators of socioeconomic status. In the non-eligible population, there was a clear association between higher vaccine coverage and greater maternal education and living with the mother. CONCLUSIONOur findings highlight the importance of public policies to minimize inequities in access to cancer prevention measures in vulnerable adolescents. A public policy of HPV vaccination for older female adolescents would increase coverage with possible reduction of HPV-related diseases in this group of women. Background Since March 2014, the quadrivalent HPV vaccine has been incorporated into the Brazilian Unified Health Care System and began to be offered, without direct costs, for girls from 9 to 13 years of age. Older female adolescents would have the option to be vaccinated at private health care system being responsible for the payment of HPV vaccine. The present study aimed to evaluate the coverage rates and predictors of HPV vaccination in Brazil among two groups of female adolescents: eligible and non-eligible for the HPV vaccination public program. Methods We used data from the 2015 Brazilian National Adolescent School-Based Health Survey, which involved a probabilistic sample of 5404 female adolescents students at public and private schools. Using a questionnaire, we gathered information on sociodemographic characteristics, sexual behavior, and respondent perception of parental supervision and have been vaccinated for HPV. Age-specific vaccination rates were analyzed in girls aged 9 to 13 at the time of public vaccination (eligible for public policy), as well among those 14 to 17 years old not eligible by the Ministry of Health for vaccination. We used Poisson regression models to investigate associated factors. Results HPV vaccine coverage was 83.5 and 21.8% among eligible and non-eligible populations, respectively. In both populations, the chance of being vaccinated decreased with older age. In the eligible population there is a greater chance of being vaccinated among ethnic group "pardas" but not with other indicators of socioeconomic status. In the non-eligible population, there was a clear association between higher vaccine coverage and greater maternal education and living with the mother. Conclusion Our findings highlight the importance of public policies to minimize inequities in access to cancer prevention measures in vulnerable adolescents. A public policy of HPV vaccination for older female adolescents would increase coverage with possible reduction of HPV-related diseases in this group of women. Keywords: HPV vaccine, Adolescents, Prevention of cervical cancer, Inequality, Risk factors |
| ArticleNumber | 458 |
| Audience | Academic |
| Author | Faisal-Cury, Alexandre Levy, Renata Bertazzi Tourinho, Maria Fernanda Grangeiro, Alexandre Eluf-Neto, José |
| Author_xml | – sequence: 1 givenname: Alexandre surname: Faisal-Cury fullname: Faisal-Cury, Alexandre email: faisal@usp.br organization: Department of Preventive Medicine Department, University of São Paulo School of Medicine, Avenida Dr Arnaldo 455, São Paulo, 01246-903, Brazil. faisal@usp.br – sequence: 2 givenname: Renata Bertazzi surname: Levy fullname: Levy, Renata Bertazzi organization: Department of Preventive Medicine Department, University of São Paulo School of Medicine, Avenida Dr Arnaldo 455, São Paulo, 01246-903, Brazil – sequence: 3 givenname: Maria Fernanda surname: Tourinho fullname: Tourinho, Maria Fernanda organization: Department of Preventive Medicine Department, University of São Paulo School of Medicine, Avenida Dr Arnaldo 455, São Paulo, 01246-903, Brazil – sequence: 4 givenname: Alexandre surname: Grangeiro fullname: Grangeiro, Alexandre organization: Department of Preventive Medicine Department, University of São Paulo School of Medicine, Avenida Dr Arnaldo 455, São Paulo, 01246-903, Brazil – sequence: 5 givenname: José surname: Eluf-Neto fullname: Eluf-Neto, José organization: Department of Preventive Medicine Department, University of São Paulo School of Medicine, Avenida Dr Arnaldo 455, São Paulo, 01246-903, Brazil |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32252705$$D View this record in MEDLINE/PubMed |
| BookMark | eNptks1u1DAUhSNURH_gBVigSGzYpPg3djZIbQW0UiVYVN1ajn2depTYg50ZCV6GV8XTKcMMoCwSXZ_z-d6bc1odhRigql5jdI6xbN9nTKTsGkRQgyRvccOeVSeYCdwQxuXR3vdxdZrzAiEsJCcvqmNKCCcC8ZPq5702xgc9-xhqE9eQ9AB10jPkWgdbLxNYb-aYch1dff31vl7vGfQUw1DD6Affj_BoKD02u4KDSW_qNo6QDYS5QOd6foD6MukffvQ6_MNcrvrRm3JxHJKeXlbPnR4zvHp6n1V3nz7eXV03t18-31xd3DaGt3RunHCUM2SF08ZS1gPhkmqJEBiDOtzSMjtCnLbcGAcOWdu3nUHQIcd70PSsutlibdQLtUx-0um7itqrx0JMg9Jp9mYExSTqiWyptYwwS0XPrSRImrJmg4ighfVhyyqTTGA3Yyc9HkAPT4J_UENcK4GpYIIXwLsnQIrfVpBnNfmyvXHUAeIqK0KlIFwwxor07V_SRVylUDZVVB3miBKK_qiG8jeUDy6We80Gqi7a0jKRneyK6vw_qvJYmLwp0XO-1A8MZGswKeacwO1mxEhtEqq2CVUloeoxoWrT8Zv97ewsvyNJfwEJoeRN |
| CitedBy_id | crossref_primary_10_1080_14760584_2022_2125383 crossref_primary_10_1590_1980_265x_tce_2020_0362 crossref_primary_10_1007_s13187_022_02183_7 crossref_primary_10_1590_1413_81232024296_03872023 crossref_primary_10_1080_21645515_2024_2326295 crossref_primary_10_1080_03630242_2022_2094045 crossref_primary_10_1080_21645515_2020_1798152 crossref_primary_10_1136_bmjopen_2022_068441 crossref_primary_10_1371_journal_pone_0258539 crossref_primary_10_4236_health_2023_152009 crossref_primary_10_3390_vaccines11030506 crossref_primary_10_1186_s12887_023_04177_w crossref_primary_10_1055_s_0041_1739314 |
| Cites_doi | 10.1016/S0140-6736(11)60055-X 10.1089/jwh.2010.1993 10.1186/s12887-017-0804-1 10.1080/03630242.2014.903552 10.1016/S0140-6736(11)60551-5 10.1016/j.vaccine.2015.01.024 10.1016/j.vaccine.2011.04.007 10.1016/S2214-109X(16)30099-7 10.1016/j.jpag.2013.08.009 10.1093/ije/dyt049 10.1016/j.vaccine.2009.12.042 10.1542/peds.2011-0950 10.1016/j.ypmed.2010.11.006 10.1016/j.vaccine.2013.03.029 10.3389/fonc.2016.00019 10.1016/j.amepre.2011.09.024 10.1002/ijc.29210 10.1080/21645515.2014.1004030 10.1200/JCO.2016.67.2014 10.2105/AJPH.85.11.1492 10.1371/journal.pone.0090912 10.1016/j.vaccine.2011 10.1016/j.vaccine.2014.07.025 10.1371/journal.pone.0062647 10.1016/j.vaccine.2012.02.007 10.1002/cncr.27894 10.1186/1471-2458-14-700 10.18637/jss.v045.i04 10.1016/j.ypmed.2013.10.009 10.1038/sj.bjc.6603469 10.1016/j.vaccine.2007.05.058 10.1590/S1413-81232010000800013 10.1016/j.vaccine.2012.04.087 10.1207/s15324796abm2602_03 10.1002/ijgo.12004 10.1001/jama.2014.95 10.1016/j.vaccine.2014.07.001 10.1016/j.ijgo.2014.03.033 10.1016/S1470-2045(15)00047-9 10.1590/S0102-311X2009000200005 10.15585/mmwr.mm6733a1 10.1093/cid/ciw354 10.1016/j.socscimed.2012.12.020 10.1542/peds.2009-3500 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2020 |
| Copyright_xml | – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2020 |
| DBID | NPM AAYXX CITATION 3V. 7T2 7X7 7XB 88E 8C1 8FE 8FG 8FI 8FJ 8FK ABJCF ABUWG AFKRA AN0 ATCPS AZQEC BENPR BGLVJ BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. L6V M0S M1P M7S PATMY PIMPY PQEST PQQKQ PQUKI PRINS PTHSS PYCSY 7X8 5PM DOA |
| DOI | 10.1186/s12889-020-08561-4 |
| DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest Central British Nursing Database Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Engineering Collection Health & Medical Collection (Alumni Edition) Medical Database Engineering Database Environmental Science Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Student Technology Collection ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest Engineering Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Agricultural & Environmental Science Collection Health & Safety Science Abstracts ProQuest Medical Library (Alumni) Engineering Collection Engineering Database ProQuest Public Health ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Environmental Science Collection ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Materials Science & Engineering Collection Environmental Science Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 1471-2458 |
| EndPage | 458 |
| ExternalDocumentID | oai_doaj_org_article_480b2863dd424d37b5d8208c458c0273 A627328989 10_1186_s12889_020_08561_4 32252705 |
| Genre | Journal Article |
| GeographicLocations | Brazil United States--US |
| GeographicLocations_xml | – name: Brazil – name: United States--US |
| GroupedDBID | --- -A0 0R~ 23N 2WC 2XV 3V. 44B 53G 5VS 6J9 6PF 7X7 7XC 88E 8C1 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAJSJ AAWTL ABDBF ABJCF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACRMQ ADBBV ADINQ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AN0 AOIJS ATCPS BAPOH BAWUL BCNDV BENPR BFQNJ BGLVJ BHPHI BMC BNQBC BPHCQ BVXVI C24 C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESTFP ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR INH INR ITC KQ8 L6V M1P M48 M7S M~E NPM O5R O5S OK1 P2P PATMY PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX CITATION 7T2 7XB 8FK AZQEC C1K DWQXO GNUQQ K9. PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c563t-f7f3540d7facd34be2583a800ecc09163001005365ccfef0ddb69c0e90f5bea3 |
| IEDL.DBID | RPM |
| ISSN | 1471-2458 |
| IngestDate | Tue Oct 22 15:13:21 EDT 2024 Tue Sep 17 21:18:39 EDT 2024 Fri Oct 25 03:05:25 EDT 2024 Thu Oct 10 20:01:07 EDT 2024 Tue Nov 19 21:01:54 EST 2024 Tue Nov 12 23:18:37 EST 2024 Thu Nov 21 22:18:45 EST 2024 Sat Sep 28 08:28:55 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Prevention of cervical cancer Adolescents HPV vaccine Risk factors Inequality |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c563t-f7f3540d7facd34be2583a800ecc09163001005365ccfef0ddb69c0e90f5bea3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137475/ |
| PMID | 32252705 |
| PQID | 2391503230 |
| PQPubID | 44782 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_480b2863dd424d37b5d8208c458c0273 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7137475 proquest_miscellaneous_2387257444 proquest_journals_2391503230 gale_infotracmisc_A627328989 gale_infotracacademiconefile_A627328989 crossref_primary_10_1186_s12889_020_08561_4 pubmed_primary_32252705 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-04-06 |
| PublicationDateYYYYMMDD | 2020-04-06 |
| PublicationDate_xml | – month: 04 year: 2020 text: 2020-04-06 day: 06 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC public health |
| PublicationTitleAlternate | BMC Public Health |
| PublicationYear | 2020 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | L Bruni (8561_CR7) 2016; 4 RB Levy (8561_CR26) 2010; 15 LN Nunes (8561_CR44) 2009; 25 SM Garland (8561_CR13) 2016; 63 T Vanni (8561_CR6) 2012; 30 H Fisher (8561_CR38) 2013; 42 8561_CR49 JA Catania (8561_CR46) 1995; 85 HB Ferrer (8561_CR14) 2014; 14 CG Victora (8561_CR31) 2011; 377 Instituto, Nacional, de, Câncer, (INCA) (8561_CR2) 2015 CG Dorell (8561_CR17) 2011; 128 NC Liddon (8561_CR22) 2012; 30 JA Tiro (8561_CR18) 2012; 30 D Figueroa-Downing (8561_CR10) 2017; 136 VK Cheruvu (8561_CR15) 2017; 17 LD Taylor (8561_CR21) 2011; 52 AN Polonijo (8561_CR12) 2013; 82 AR Kreimer (8561_CR47) 2015; 16 E Herweijer (8561_CR48) 2014; 311 M Poljak (8561_CR29) 2013; 31 AL Beavis (8561_CR35) 2016; 6 KE Schroder (8561_CR45) 2003; 26 L Rambout (8561_CR39) 2014; 58 JH Fregnani (8561_CR30) 2013; 8 BT Hansen (8561_CR43) 2014; 32 AL McRee (8561_CR36) 2014; 32 NC Liddon (8561_CR20) 2012; 42 J Lechuga (8561_CR19) 2011; 20 IBGE (8561_CR25) 2016 HH Bailey (8561_CR32) 2016; 34 M Rondy (8561_CR23) 2010; 28 P Royston (8561_CR27) 2011; 45 S Reagan-Steiner (8561_CR8) 2016; 65 ML Baker (8561_CR50) 2015; 38 JM Brotherton (8561_CR5) 2011; 377 GM Chadenier (8561_CR24) 2011; 29 J Ferlay (8561_CR1) 2015; 136 TH Laz (8561_CR37) 2013; 119 MB Rysavy (8561_CR42) 2014; 27 S Perlman (8561_CR11) 2014; 9 SJ Goldie (8561_CR28) 2007; 25 MF Daley (8561_CR9) 2010; 126 ES Lefkowitz (8561_CR34) 2014; 54 8561_CR33 AM Ruiz-Sternberg (8561_CR41) 2014; 126 International, Agency, for, Research, on, Cancer (8561_CR3) 2007 K Canfell (8561_CR40) 2015; 33 A Krawczyk (8561_CR16) 2015; 11 LL Villa (8561_CR4) 2006; 95 |
| References_xml | – volume: 377 start-page: 2042 year: 2011 ident: 8561_CR31 publication-title: Lancet doi: 10.1016/S0140-6736(11)60055-X contributor: fullname: CG Victora – volume: 20 start-page: 225 year: 2011 ident: 8561_CR19 publication-title: J Women's Health (Larchmt) doi: 10.1089/jwh.2010.1993 contributor: fullname: J Lechuga – volume-title: Estimativa 2016: Incidência de Câncer no Brasil year: 2015 ident: 8561_CR2 contributor: fullname: Instituto, Nacional, de, Câncer, (INCA) – volume: 17 start-page: 52 year: 2017 ident: 8561_CR15 publication-title: BMC Pediatr doi: 10.1186/s12887-017-0804-1 contributor: fullname: VK Cheruvu – volume: 54 start-page: 487 year: 2014 ident: 8561_CR34 publication-title: Women Health doi: 10.1080/03630242.2014.903552 contributor: fullname: ES Lefkowitz – volume: 377 start-page: 2085 year: 2011 ident: 8561_CR5 publication-title: Lancet doi: 10.1016/S0140-6736(11)60551-5 contributor: fullname: JM Brotherton – volume: 33 start-page: 2387 year: 2015 ident: 8561_CR40 publication-title: Vaccine doi: 10.1016/j.vaccine.2015.01.024 contributor: fullname: K Canfell – volume: 29 start-page: 4405 year: 2011 ident: 8561_CR24 publication-title: Vaccine doi: 10.1016/j.vaccine.2011.04.007 contributor: fullname: GM Chadenier – volume: 4 start-page: e453 year: 2016 ident: 8561_CR7 publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(16)30099-7 contributor: fullname: L Bruni – volume: 27 start-page: 67 year: 2014 ident: 8561_CR42 publication-title: J Pediatr Adolesc Gynecol doi: 10.1016/j.jpag.2013.08.009 contributor: fullname: MB Rysavy – volume: 42 start-page: 896 year: 2013 ident: 8561_CR38 publication-title: Int J Epidemiol doi: 10.1093/ije/dyt049 contributor: fullname: H Fisher – volume: 28 start-page: 2070 year: 2010 ident: 8561_CR23 publication-title: Vaccine doi: 10.1016/j.vaccine.2009.12.042 contributor: fullname: M Rondy – volume: 128 start-page: 830 year: 2011 ident: 8561_CR17 publication-title: Pediatrics doi: 10.1542/peds.2011-0950 contributor: fullname: CG Dorell – volume: 52 start-page: 398 year: 2011 ident: 8561_CR21 publication-title: Prev Med doi: 10.1016/j.ypmed.2010.11.006 contributor: fullname: LD Taylor – volume: 31 start-page: H59 issue: Suppl 7 year: 2013 ident: 8561_CR29 publication-title: Vaccine doi: 10.1016/j.vaccine.2013.03.029 contributor: fullname: M Poljak – volume: 6 start-page: 19 year: 2016 ident: 8561_CR35 publication-title: Front Oncol doi: 10.3389/fonc.2016.00019 contributor: fullname: AL Beavis – volume: 42 start-page: 44 year: 2012 ident: 8561_CR20 publication-title: Am J Prev Med doi: 10.1016/j.amepre.2011.09.024 contributor: fullname: NC Liddon – volume: 136 start-page: E359 year: 2015 ident: 8561_CR1 publication-title: Int J Cancer doi: 10.1002/ijc.29210 contributor: fullname: J Ferlay – volume: 11 start-page: 322 year: 2015 ident: 8561_CR16 publication-title: Hum Vaccin Immunother doi: 10.1080/21645515.2014.1004030 contributor: fullname: A Krawczyk – volume: 38 start-page: 163 year: 2015 ident: 8561_CR50 publication-title: Rev Panam Salud Publica contributor: fullname: ML Baker – volume: 34 start-page: 1803 year: 2016 ident: 8561_CR32 publication-title: J Clin Oncol doi: 10.1200/JCO.2016.67.2014 contributor: fullname: HH Bailey – volume: 85 start-page: 1492 year: 1995 ident: 8561_CR46 publication-title: Am J Public Health doi: 10.2105/AJPH.85.11.1492 contributor: fullname: JA Catania – volume: 9 start-page: e90912 year: 2014 ident: 8561_CR11 publication-title: PLoS One doi: 10.1371/journal.pone.0090912 contributor: fullname: S Perlman – volume: 30 start-page: 2368 year: 2012 ident: 8561_CR18 publication-title: Vaccine doi: 10.1016/j.vaccine.2011 contributor: fullname: JA Tiro – volume: 32 start-page: 4945 year: 2014 ident: 8561_CR43 publication-title: Vaccine doi: 10.1016/j.vaccine.2014.07.025 contributor: fullname: BT Hansen – volume: 8 start-page: e62647 year: 2013 ident: 8561_CR30 publication-title: PLoS One doi: 10.1371/journal.pone.0062647 contributor: fullname: JH Fregnani – volume: 30 start-page: 2676 year: 2012 ident: 8561_CR22 publication-title: Vaccine doi: 10.1016/j.vaccine.2012.02.007 contributor: fullname: NC Liddon – volume: 119 start-page: 1386 year: 2013 ident: 8561_CR37 publication-title: Cancer. doi: 10.1002/cncr.27894 contributor: fullname: TH Laz – volume: 14 start-page: 700 year: 2014 ident: 8561_CR14 publication-title: BMC Public Health doi: 10.1186/1471-2458-14-700 contributor: fullname: HB Ferrer – volume: 45 start-page: 1 issue: 4 year: 2011 ident: 8561_CR27 publication-title: J Stat Softw doi: 10.18637/jss.v045.i04 contributor: fullname: P Royston – ident: 8561_CR33 – volume: 58 start-page: 22 year: 2014 ident: 8561_CR39 publication-title: Prev Med doi: 10.1016/j.ypmed.2013.10.009 contributor: fullname: L Rambout – volume: 95 start-page: 1459 year: 2006 ident: 8561_CR4 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6603469 contributor: fullname: LL Villa – volume-title: IARC monographs on the evaluation of carcinogenic risks to humans. Volume 90: human papillomaviruses year: 2007 ident: 8561_CR3 contributor: fullname: International, Agency, for, Research, on, Cancer – volume: 25 start-page: 6257 year: 2007 ident: 8561_CR28 publication-title: Vaccine doi: 10.1016/j.vaccine.2007.05.058 contributor: fullname: SJ Goldie – volume: 15 start-page: 3085 issue: Suppl 2 year: 2010 ident: 8561_CR26 publication-title: Cien Saude Colet doi: 10.1590/S1413-81232010000800013 contributor: fullname: RB Levy – volume: 30 start-page: 4866 year: 2012 ident: 8561_CR6 publication-title: Vaccine doi: 10.1016/j.vaccine.2012.04.087 contributor: fullname: T Vanni – volume: 26 start-page: 104 year: 2003 ident: 8561_CR45 publication-title: Ann Behav Med doi: 10.1207/s15324796abm2602_03 contributor: fullname: KE Schroder – volume: 136 start-page: 33 year: 2017 ident: 8561_CR10 publication-title: Int J Gynaecol Obstet doi: 10.1002/ijgo.12004 contributor: fullname: D Figueroa-Downing – volume: 311 start-page: 597 year: 2014 ident: 8561_CR48 publication-title: JAMA. doi: 10.1001/jama.2014.95 contributor: fullname: E Herweijer – volume: 32 start-page: 4736 year: 2014 ident: 8561_CR36 publication-title: Vaccine doi: 10.1016/j.vaccine.2014.07.001 contributor: fullname: AL McRee – volume: 126 start-page: 205 year: 2014 ident: 8561_CR41 publication-title: Int J Gynaecol Obstet doi: 10.1016/j.ijgo.2014.03.033 contributor: fullname: AM Ruiz-Sternberg – volume: 16 start-page: 775 year: 2015 ident: 8561_CR47 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(15)00047-9 contributor: fullname: AR Kreimer – volume: 25 start-page: 268 year: 2009 ident: 8561_CR44 publication-title: Cad Saude Publica doi: 10.1590/S0102-311X2009000200005 contributor: fullname: LN Nunes – volume: 65 start-page: 850 year: 2016 ident: 8561_CR8 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm6733a1 contributor: fullname: S Reagan-Steiner – volume: 63 start-page: 519 year: 2016 ident: 8561_CR13 publication-title: Clin Infect Dis doi: 10.1093/cid/ciw354 contributor: fullname: SM Garland – volume: 82 start-page: 115 year: 2013 ident: 8561_CR12 publication-title: Soc Sci Med doi: 10.1016/j.socscimed.2012.12.020 contributor: fullname: AN Polonijo – start-page: 132 volume-title: Pesquisa nacional de saúde do escolar: 2015.Coordenação de População e Indicadores Sociais year: 2016 ident: 8561_CR25 contributor: fullname: IBGE – volume: 126 start-page: 425 year: 2010 ident: 8561_CR9 publication-title: Pediatrics doi: 10.1542/peds.2009-3500 contributor: fullname: MF Daley – ident: 8561_CR49 |
| SSID | ssj0017852 |
| Score | 2.421827 |
| Snippet | Since March 2014, the quadrivalent HPV vaccine has been incorporated into the Brazilian Unified Health Care System and began to be offered, without direct... Background Since March 2014, the quadrivalent HPV vaccine has been incorporated into the Brazilian Unified Health Care System and began to be offered, without... BACKGROUNDSince March 2014, the quadrivalent HPV vaccine has been incorporated into the Brazilian Unified Health Care System and began to be offered, without... Abstract Background Since March 2014, the quadrivalent HPV vaccine has been incorporated into the Brazilian Unified Health Care System and began to be offered,... |
| SourceID | doaj pubmedcentral proquest gale crossref pubmed |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | 458 |
| SubjectTerms | Adolescents Age Cancer prevention Cervical cancer Health care Health insurance HPV vaccine Human papillomavirus Immunization Inequality Medical research Minority & ethnic groups Populations Prevention of cervical cancer Public policy Regression analysis Regression models Risk factors Schools Sexual behavior Socioeconomic factors Socioeconomics Statistical analysis Students Studies Surveys Teenage girls Teenagers Vaccination Vaccines |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1JixQxFA46J0HE3dJRIggepJiqLJXUcUZn6JMIDoO3kBUbtHroZQ7-Gf-q7yXVZRdz8OI1S5HUW_KSfPkeIe84Iru1cjXSu9XCKVa7Vri6tTz2EMAGkXMRLL6qz9_0p3OkyZlSfSEmrNADlx93InTjmO54gF4icOVkgEVLeyG1Ry6W7H2bbr-ZGu8PlJZs_0RGdycb8MIIDWKI3YKIoRazZSiz9d_2yQeL0hwwebACXTwkD8bQkZ6WIT8id-LwmNwv5260PCd6Qn5fWe-X5YiPesRngsOgyAexoXYI9HqNNzOYYoeuEl18uaI3Bx1y6iGaUcruR8wdhtVQTwUp_rRY_pcGitothRiSnq3tryUemdz6ZiHSpiMQ7Cm5vDi__LioxyQMtZcd39ZJJTwaCipZH7hwkUnNLYSZIHuINZCxq0VL7qT3KaYmBNf1vol9k6SLlj8jRzDQ-IJQqz1vkw2KxyiUZX2w1sUkeR_7INtUkQ97kZjrQrVh8hZFd6YI0IAATRagERU5Q6lNLZEmOxeA8phRecy_lKci71HmBo0ZBOvt-CYBBoy0WOa0Y0hm1Ou-IsezlmCEfl691xozOoGNYUi-33DY5FXk7VSNPRHYNsTVDttoBV5TCJjQ86Jk05TQ1zLVyIqomfrN5jyvGZbfM0W4ajnsE-XL__GTXpF7LFuOqJvumBxt17v4mtzdhN2bbHR_ANW-MXQ priority: 102 providerName: Directory of Open Access Journals |
| Title | Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/32252705 https://www.proquest.com/docview/2391503230 https://search.proquest.com/docview/2387257444 https://pubmed.ncbi.nlm.nih.gov/PMC7137475 https://doaj.org/article/480b2863dd424d37b5d8208c458c0273 |
| Volume | 20 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbYnpAQ4k2gVEZC4oDSTWI7do5tabUXUCWqipvlJ6zUza72wYE_w19lxkmWjXrj6kdkax4eTz5_Q8gHhshuJW2O9G45t7LKbcltXhoWGghgPU-1CGbf5Nfv6vMl0uSI4S1MAu07Oz9t7xan7fxnwlauFm464MSm118u4GIFUbCYTsgEYsPhit7_OpBKVMPrGFVPN-CAERVUIWwLgoUcK_GgFlcSS9YdHEaJs_--Zz44msawyYNz6OoJedwHkPSsW-hT8iC0z8ijLvtGu0dFz8mfW-PcvEv0UYcoTXAbFFkhNtS0nq7W-H8GC-3QZaSz61v662BCKkBEE1bZ3oU0oV22-b4hhoXB9n9kUNRsKUSS9Hxtfs8xcXLvmx2dNu3hYC_IzdXlzcUs70sx5E7UbJtHGTFB5GU0zjNuQyUUMxBsggZAxIG8XSXacy2ciyEW3tu6cUVoiihsMOwlOYKFhteEGuVYGY2XLAQuTdV4Y2yIgjWh8aKMGfk0iESvOsINnS4qqtadLDXIUidZap6Rc5TafiSSZaeG5fqH7lVGc1XYStXMg-Jxz6QVHuIe5bhQDul8MvIRZa7RpEGwzvQvE2DBSI6lz-oKKY0a1WTkeDQSTNGNuwet0b0r2OgKKfgLBle9jLzfd-NMhLe1YbnDMUqC7-QcNvSqU7L9lgZdzYgcqd9oz-MesJtEFN7byZv_nvmWPKyS5fC8qI_J0Xa9C-_IZON3Jyl5cZJM7y_H5DRN |
| link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53800,53802 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZoOYBU8YYGChgJiQNKNxs7sXNsS6tFtFUlVhU3y09YqZtd7YMDf4a_yoyTLBv11qvtiWL583hsf_6GkI8Mmd1SmBTl3VJuRJ6aITfpUDNfQQDreMxFMPouLn_IL6cok1N0b2Eiad-ayWF9Mz2sJ78it3I-tYOOJza4ujiBjRVEwcVgh9yH-Zpl3Sa9vTwQssi79zGyHCzBBSMvKEfiFoQLKebiQRznApPWbS1HUbX_tm_eWpz6xMmtlejs8R378IQ8akNPetRUPyX3fP2M7DXndrR5jvSc_L3W1k6aI0Jqkd8JDoeinsSS6trR-QJvdjBFD50FOrq6pr-3DGLqIhpZzubGR4N6VqebguCnGsv_y0hRvaIQg9Ljhf4zwSOXW99shLhpSyR7QcZnp-OTUdomcUhtUbJVGkTAoyUngraOcePzQjINgwbYgVgFFb-G6AnKwtrgQ-acKSub-SoLhfGavSS78KN-n1AtLRsG7QTzngudV05r40PBKl-5YhgS8rkbSjVvpDpU3OLIUjUYUIABFTGgeEKOcbQ3LVFmOxbMFj9VO1CKy8zksmQOIMsdE6ZwEDFJywtpUQgoIZ8QKwqdAQDC6vZNA_wwymqpozJHMaRKVgk56LWESWz71R3aVOtElipH8f6MwSYxIR821WiJxLjaz9bYRgrwupxDh1414Nx0qcN4QkQPtr0-92sArVFivEXn6ztbvicPRuOLc3X-9fLbG_Iwj7OPp1l5QHZXi7V_S3aWbv0uTtx_MUJI4g |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bi9QwFA7uCiKI99XqqhEEH6Q7nSZt0se9DSPqMuCy-BZy1YGdzjAXH_wz_lXPSdtxyr7pa5JTGvLl5CT58h1C3jFkdkthUpR3S7kReWqG3KRDzXwFAazjMRfB-Ku4-CbPzlEmZ5vqK5L2rZke1dezo3r6I3IrFzM76Hhig8mXU9hYQRRcDBYuDPbIbZizWd5t1NsLBCGLvHsjI8vBCtwwcoNyJG9ByJBiPh7Eci4wcd3OkhSV-2_6550Fqk-e3FmNRg_-ox8Pyf02BKXHTZNH5JavH5N7zfkdbZ4lPSG_r7S10-aokFrkeYLjoagrsaK6dnSxxBseTNVD54GOJ1f0545BTGFEI9vZXPtoUM_rdFsQ_Exj-V85KarXFGJRerLUv6Z49HLjm40gN20JZU_J5ej88nSctskcUluUbJ0GEfCIyYmgrWPc-LyQTEO4ChiCmAWVv4boEcrC2uBD5pwpK5v5KguF8ZodkH34Uf-cUC0tGwbtBPOeC51XTmvjQ8EqX7liGBLyoRtOtWgkO1Tc6shSNThQgAMVcaB4Qk5wxLctUW47FsyX31U7WIrLzOSyZA6gyx0TpnAQOUnLC2lRECgh7xEvCp0CgMLq9m0D_DDKa6njMkdRpEpWCTnstYTJbPvVHeJU60xWKkcR_4zBZjEhb7fVaIkEudrPN9hGCvC-nEOHnjUA3Xapw3lCRA-6vT73awCxUWq8ReiLf7Z8Q-5Mzkbq88eLTy_J3TxOQJ5m5SHZXy83_hXZW7nN6zh3_wBd7Eti |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vaccination+coverage+rates+and+predictors+of+HPV+vaccination+among+eligible+and+non-eligible+female+adolescents+at+the+Brazilian+HPV+vaccination+public+program&rft.jtitle=BMC+public+health&rft.au=Faisal-Cury%2C+Alexandre&rft.au=Renata+Bertazzi+Levy&rft.au=Tourinho%2C+Maria+Fernanda&rft.au=Grangeiro%2C+Alexandre&rft.date=2020-04-06&rft.pub=BioMed+Central&rft.eissn=1471-2458&rft.volume=20&rft.spage=1&rft_id=info:doi/10.1186%2Fs12889-020-08561-4 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon |